RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups
Li, W.-Q., Ma, J.-L., Zhang, L., Brown, L. M., Li, J.-Y., Shen, L., Pan, K.-F., Liu, W.-D., Hu, Y., Han, Z.-X., Crystal-Mansour, S., Pee, D., Blot, W. J., Fraumeni, J. F., You, W.-C., & Gail, M. H. (2014). Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. Journal of the National Cancer Institute, 106(7), Article dju116. https://doi.org/10.1093/jnci/dju116
Among 2258 Helicobacter pylori-seropositive subjects randomly assigned to receive one-time H. pylori treatment with amoxicillin-omeprazole or its placebo, we evaluated the 15-year effect of treatment on gastric cancer incidence and mortality in subgroups defined by age, baseline gastric histopathology, and post-treatment infection status. We used conditional logistic and Cox regressions for covariable adjustments in incidence and mortality analyses, respectively. Treatment was associated with a statistically significant decrease in gastric cancer incidence (odds ratio = 0.36; 95% confidence interval [CI] = 0.17 to 0.79) and mortality (hazard ratio = 0.26; 95% CI = 0.09 to 0.79) at ages 55 years and older and a statistically significant decrease in incidence among those with intestinal metaplasia or dysplasia at baseline (odds ratio = 0.56; 95% CI = 0.34 to 0.91). Treatment benefits for incidence and mortality among those with and without post-treatment infection were similar. Thus H. pylori treatment can benefit older members and those with advanced baseline histopathology, and benefits are present even with post-treatment infection, suggesting treatment can benefit an entire population, not just the young or those with mild histopathology.
